PharmaDispatch - PharmaDispatch

Comment
A relationship that works for patients

Researchers at the University of Sydney have remarkably found a correlation between a company's product portfolio and the patient groups it funds.

Latest News Clock ticking as caretaker approaches January 17, 2019
The clock is ticking towards the election caretaker period with companies contemplating the potential impact on progressing their PBAC recommendations.
Latest News Pharmaxis updates on LOXL2 studies January 18, 2019
Sydney-based Pharmaxis (ASX:PXS) has announced it has now received reports on all of the 13‐week toxicity studies conducted for each of its two Lysyl Oxidase Like 2 (LOXL2) inhibitors.
Latest News Novo Nordisk's Michala Fischer-Hansen returning to Denmark January 17, 2019
A promotion for Novo Nordisk's Michala Fischer-Hansen with the company's general manager for Australia and NZ returning to its Danish headquarters.
Latest News The genesis of the policy that continues to shape PBS discussions January 17, 2019
The recent release of Cabinet documents from 1996 included an outline of an option for the PBS that evolved into an outcome that continues to shape PBS policy discussions two decades later.
Latest News Takeda rings the bell in New York January 17, 2019
Takeda's Australian chief financial officer Costa Saroukos has joined the company's CEO and other executives in ringing the bell at the New York Stock Exchange to mark the company's listing in the US.
Latest News Fundraising underway in the race for #PharmaCup2019 January 16, 2019
Janssen is the early leader in the race for the 2019 for Rare Cancers Australia 'Pharma 2 Peak Kosi Challenge' cup.
Latest News PharmaDispatch 2019: Renewed focus on supply chain December 6, 2018
DHL's Saul Resnick, leading pharmacy compounder David Slade and Mundipharma's managing director Jane Orr, are the latest to confirm their participation in PharmaDispatch 2019.
Latest News Pfizer adopts 'agile' working January 15, 2019
In the second part of the video series on Pfizer's move to the Sydney CBD, and as part of the new 'MyPharmaSpace' section, the company's employees discuss its new approach to working.
Latest News New report highlights the demise of F2 January 15, 2019
The 2017-18 PBS Expenditure and Prescriptions Report highlights the substantial decline in the PBS category comprised of off-patent and multiple branded medicines.
Comment Where will the money come from now? January 15, 2019
The PBS pie is not growing and the structural reforms that have delivered billions in savings are close to exhausted - where will the money come from and is conflict inevitable?
Latest News Information forums on PBS fee hike January 15, 2019
The Department of Health has invited stakeholders to information sessions on new PBS cost recovery arrangements and what it describes as "process improvements".
'MyPharmaSpace' Pfizer makes its CBD move January 14, 2019
A new 'MyPharmaSpace' section in PharmaDispatch debuts in 2019 with part one of an exclusive video review of Pfizer's new Sydney CBD office and its 'agile' approach to working.
Latest News NPS MedicineWise under scrutiny January 14, 2019
The review of NPS MedicineWise will evaluate its programs, the savings it claims to make, and the impact of its commercial arm.
Latest News New report confirms 'exaggerated' spend on medicines January 14, 2019
Publication of the 2017-18 PBS Expenditure and Prescriptions Report has revealed just how little the government spends on the actual cost of reimbursing new and patented medicines.
Latest News Where does the government spend its investment in the PBS? January 14, 2019
Publication of the 2017-18 PBS Expenditure and Prescriptions Report has revealed how the government spends its investment on the PBS.

News of the Day

Latest Video

Most Read

New Stories